Time-Course Changes of Serum Keratin Concentrations after Liver Transplantation: Contrasting Results of Keratin-18 and Keratin-19 Fragments

Table 1

Patient characteristics.

Patient number	Age (y)/sex	Indication for transplantation	Ischemia time (min)	Complications after transplantation
1	56/M	Cirrhosis (alcohol plus HCV)	260	Recurrent HCV hepatitis
2	56/F	Cirrhosis (alcohol) and hepatocellular carcinoma	720	None
3	45/F	Cirrhosis (alcohol)	690	De novo diabetes mellitus
4	43/M	Cirrhosis (alcohol)	360	Acute cellular rejection (day +33); de novo diabetes mellitus
5	53/M	Cirrhosis (alcohol)	700	Acute cellular rejection (day +10)
6	40/F	Cirrhosis (alcohol)	240	Intestinal obstruction (umbilical hernia)
7	62/F	Cirrhosis (autoimmune)	420	None
8	58/M	Cirrhosis (alcohol)	300	Mild kidney failure
9	55/M	Cirrhosis (HBV) and hepatocellular carcinoma	630	None
10	64/M	Cirrhosis (HCV)	360	Recurrent HCV hepatitis
11	61/M	Cirrhosis (alcohol)	300	Acute cellular rejection (day +56); de novo diabetes mellitus; mild kidney failure

HBV, hepatitis B virus; HCV, hepatitis C virus. The initial immunosuppression regime included tacrolimus and corticosteroids in all cases.